Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2026 Filed Jun 25, 2026 20:01 UTC |
PARSHALL B LYNNEDirector
|
GrantStock Options (Right to buy) · Derivative | 28,000 | $4.08 Strike: $4.08 | $114,240.00 |
DisclosureSEC source: 0001073385-26-000004 · primarydocument.xml · derivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 20:04 UTC |
Gallagher NeilDirector
|
GrantStock Options (Right to buy) · Derivative | 28,000 | $4.08 Strike: $4.08 | $114,240.00 |
DisclosureSEC source: 0001972849-26-000004 · primarydocument.xml · derivative · entry 1 Gallagher Neil · CIK 0001972849 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 20:01 UTC |
GILL SIMBADirector
|
GrantStock Options (Right to buy) · Derivative | 28,000 | $4.08 Strike: $4.08 | $114,240.00 |
DisclosureSEC source: 0001180763-26-000005 · primarydocument.xml · derivative · entry 1 GILL SIMBA · CIK 0001180763 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 20:00 UTC |
Cole Douglas G.Director
|
GrantStock Options (Right to buy) · Derivative | 28,000 | $4.08 Strike: $4.08 | $114,240.00 |
DisclosureSEC source: 0001486373-26-000005 · primarydocument.xml · derivative · entry 1 Cole Douglas G. · CIK 0001486373 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 20:06 UTC |
Lynch Thomas J. Jr.Director
|
GrantStock Options (Right to buy) · Derivative | 28,000 | $4.08 Strike: $4.08 | $114,240.00 |
DisclosureSEC source: 0001474056-26-000007 · primarydocument.xml · derivative · entry 1 Lynch Thomas J. Jr. · CIK 0001474056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 20:02 UTC |
SMITH IAN FDirector
|
GrantStock Options (Right to buy) · Derivative | 28,000 | $4.08 Strike: $4.08 | $114,240.00 |
DisclosureSEC source: 0001197032-26-000005 · primarydocument.xml · derivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 20:05 UTC |
Biller ScottDirector
|
GrantStock Options (Right to buy) · Derivative | 28,000 | $4.08 Strike: $4.08 | $114,240.00 |
DisclosureSEC source: 0001581956-26-000004 · primarydocument.xml · derivative · entry 1 Biller Scott · CIK 0001581956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 20:03 UTC |
Mendelsohn MichaelDirector
|
GrantStock Options (Right to buy) · Derivative | 28,000 | $4.08 Strike: $4.08 | $114,240.00 |
DisclosureSEC source: 0001591109-26-000004 · primarydocument.xml · derivative · entry 1 Mendelsohn Michael · CIK 0001591109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 20:06 UTC |
Duty StuartDirector
|
GrantStock Options (Right to buy) · Derivative | 28,000 | $4.08 Strike: $4.08 | $114,240.00 |
DisclosureSEC source: 0001970274-26-000007 · primarydocument.xml · derivative · entry 1 Duty Stuart · CIK 0001970274 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 59,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001828724-26-000005 · primarydocument.xml · nonDerivative · entry 4 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Living Trust Disclosed balance after: 270,912 F2 · kind: On April 10, 2026, the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025, of which the Reporting Person is the trustee and sole current beneficiary (the "2025 GRAT"), distributed 59,208 shares of the Issuer's Common Stock to the Living Trust. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 59,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001828724-26-000005 · primarydocument.xml · nonDerivative · entry 3 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · 2025 GRAT Disclosed balance after: 240,792 F2 · kind: On April 10, 2026, the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025, of which the Reporting Person is the trustee and sole current beneficiary (the "2025 GRAT"), distributed 59,208 shares of the Issuer's Common Stock to the Living Trust. Read SEC document |
| April 09, 2026 Filed Apr 13, 2026 20:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 47,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001828724-26-000005 · primarydocument.xml · nonDerivative · entry 2 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Living Trust Disclosed balance after: 211,704 F1 · kind: On April 9, 2026, the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary (the "2023 GRAT"), distributed 47,497 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee (the "Living Trust"). Read SEC document |
| April 09, 2026 Filed Apr 13, 2026 20:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 47,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001828724-26-000005 · primarydocument.xml · nonDerivative · entry 1 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By 2023 GRAT Disclosed balance after: 0 F1 · kind: On April 9, 2026, the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary (the "2023 GRAT"), distributed 47,497 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee (the "Living Trust"). Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:02 UTC |
Maynard Ryan DChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 400,000 | $5.75 Strike: $5.75 | $2,300,000.00 |
DisclosureSEC source: 0001363984-26-000004 · primarydocument.xml · derivative · entry 1 Maynard Ryan D · CIK 0001363984 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2036-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on February 23, 2027, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 21:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GrantStock option (right to buy) · Derivative | 1,075,000 | $5.23 Strike: $5.23 | $5,622,250.00 |
DisclosureSEC source: 0001828724-26-000003 · primarydocument.xml · derivative · entry 1 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,075,000 Underlying: Common Stock · 1,075,000 shares Expires 2036-02-04 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on February 5, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 16:02 UTC |
Rivkin AnnaChief Business Officer
|
GrantStock option (right to buy) · Derivative | 165,000 | $5.71 Strike: $5.71 | $942,150.00 |
DisclosureSEC source: 0002035647-26-000002 · primarydocument.xml · derivative · entry 1 Rivkin Anna · CIK 0002035647 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 165,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 16:03 UTC |
Cardama Alfonso QuintasChief Medical Officer
|
GrantStock option (right to buy) · Derivative | 300,000 | $5.71 Strike: $5.71 | $1,713,000.00 |
DisclosureSEC source: 0001760104-26-000002 · primarydocument.xml · derivative · entry 1 Cardama Alfonso Quintas · CIK 0001760104 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:04 UTC |
Costa CarlosChief People Officer
|
GrantStock option (right to buy) · Derivative | 230,000 | $5.71 Strike: $5.71 | $1,313,300.00 |
DisclosureSEC source: 0001939167-26-000002 · primarydocument.xml · derivative · entry 1 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,000 Underlying: Common Stock · 230,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:03 UTC |
LaCascia MichaelChief Legal Officer
|
GrantStock option (right to buy) · Derivative | 295,000 | $5.71 Strike: $5.71 | $1,684,450.00 |
DisclosureSEC source: 0001831755-26-000002 · primarydocument.xml · derivative · entry 1 LaCascia Michael · CIK 0001831755 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,000 Underlying: Common Stock · 295,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:01 UTC |
Bellon Steven F.Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 300,000 | $5.71 Strike: $5.71 | $1,713,000.00 |
DisclosureSEC source: 0001831749-26-000002 · primarydocument.xml · derivative · entry 1 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 17:00 UTC |
Flagship Pioneering, LLCDirector · 10% owner
Flagship Pioneering Fund VII General Partner LLCDirector · 10% owner
Flagship Pioneering Fund VII, L.P.Director · 10% owner
Flagship Pioneering Special Opportunities Fund II General Partner LLCDirector · 10% owner
Flagship Pioneering Special Opportunities Fund II, L.P.Director · 10% owner
Flagship Ventures Fund V General Partner LLCDirector · 10% owner
Flagship Ventures Fund V, L.P.Director · 10% owner
Flagship Ventures Opportunities Fund I General Partner LLCDirector · 10% owner
Flagship Ventures Opportunities Fund I, L.P.Director · 10% owner
Afeyan NoubarDirector · 10% owner
|
GrantSeries 2 Warrants to purchase Common Stock · Derivative | 1,117,734 | Not disclosed Strike: $20.13 | Not disclosed |
DisclosureSEC source: 0001193125-26-014218 · ownership.xml · derivative · entry 3 Flagship Pioneering, LLC · CIK 0001400240 · Director · 10% owner Flagship Pioneering Fund VII General Partner LLC · CIK 0001805917 · Director · 10% owner Flagship Pioneering Fund VII, L.P. · CIK 0001805916 · Director · 10% owner Flagship Pioneering Special Opportunities Fund II General Partner LLC · CIK 0001826217 · Director · 10% owner Flagship Pioneering Special Opportunities Fund II, L.P. · CIK 0001761283 · Director · 10% owner Flagship Ventures Fund V General Partner LLC · CIK 0001724575 · Director · 10% owner Flagship Ventures Fund V, L.P. · CIK 0001627639 · Director · 10% owner Flagship Ventures Opportunities Fund I General Partner LLC · CIK 0001725004 · Director · 10% owner Flagship Ventures Opportunities Fund I, L.P. · CIK 0001677345 · Director · 10% owner AFEYAN NOUBAR · CIK 0001222012 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Flagship Pioneering Fund VII, L.P. Disclosed balance after: 1,117,734 Underlying: Common Stock · 1,117,734 shares Expires 2030-12-31 F3 · derivative.exercise_price: The Series Warrants are exercisable at an initial price of $13.42 per Series 1 Warrant and $20.13 per Series 2 Warrant. Subject to certain exclusions, if prior to June 30, 2027, the Company issues capital stock or securities convertible into or exercisable for capital stock in one or more related transactions primarily for capital raising at a weighted-average common stock equivalent price (the "Weighted-Average Price") below $13.42 per share, the exercise price of a Series Warrant shall reset upon exercise to the midpoint between the initial price and the lowest such Weighted-Average Price, but not below $6.71 per share. The exercise price may be adjusted only once pursuant to this mechanism. F1 · price: On January 13, 2026, pursuant to a registered direct offering by the Issuer, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired warrants to purchase an aggregate of 4,470,936 shares of Common Stock, consisting of (i) Pre-Funded Warrants to purchase 2,235,468 shares of Common Stock, (ii) Series 1 Warrants to purchase 1,117,734 shares of Common Stock and (iii) Series 2 Warrants to purchase 1,117,734 shares of Common Stock (together with the Series 1 Warrants, the "Series Warrants"). The securities were acquired for a purchase price of $6.7099 per Pre-Funded Warrant and accompanying Series Warrants. F2 · ownership.nature: Securities held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, LLC (f/k/a Flagship Pioneering, Inc., "Flagship Pioneering") is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the ultimate control person of Flagship Pioneering. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 17:00 UTC |
Flagship Pioneering, LLCDirector · 10% owner
Flagship Pioneering Fund VII General Partner LLCDirector · 10% owner
Flagship Pioneering Fund VII, L.P.Director · 10% owner
Flagship Pioneering Special Opportunities Fund II General Partner LLCDirector · 10% owner
Flagship Pioneering Special Opportunities Fund II, L.P.Director · 10% owner
Flagship Ventures Fund V General Partner LLCDirector · 10% owner
Flagship Ventures Fund V, L.P.Director · 10% owner
Flagship Ventures Opportunities Fund I General Partner LLCDirector · 10% owner
Flagship Ventures Opportunities Fund I, L.P.Director · 10% owner
Afeyan NoubarDirector · 10% owner
|
GrantSeries 1 Warrants to purchase Common Stock · Derivative | 1,117,734 | Not disclosed Strike: $13.42 | Not disclosed |
DisclosureSEC source: 0001193125-26-014218 · ownership.xml · derivative · entry 2 Flagship Pioneering, LLC · CIK 0001400240 · Director · 10% owner Flagship Pioneering Fund VII General Partner LLC · CIK 0001805917 · Director · 10% owner Flagship Pioneering Fund VII, L.P. · CIK 0001805916 · Director · 10% owner Flagship Pioneering Special Opportunities Fund II General Partner LLC · CIK 0001826217 · Director · 10% owner Flagship Pioneering Special Opportunities Fund II, L.P. · CIK 0001761283 · Director · 10% owner Flagship Ventures Fund V General Partner LLC · CIK 0001724575 · Director · 10% owner Flagship Ventures Fund V, L.P. · CIK 0001627639 · Director · 10% owner Flagship Ventures Opportunities Fund I General Partner LLC · CIK 0001725004 · Director · 10% owner Flagship Ventures Opportunities Fund I, L.P. · CIK 0001677345 · Director · 10% owner AFEYAN NOUBAR · CIK 0001222012 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Flagship Pioneering Fund VII, L.P. Disclosed balance after: 1,117,734 Underlying: Common Stock · 1,117,734 shares Expires 2027-06-30 F3 · derivative.exercise_price: The Series Warrants are exercisable at an initial price of $13.42 per Series 1 Warrant and $20.13 per Series 2 Warrant. Subject to certain exclusions, if prior to June 30, 2027, the Company issues capital stock or securities convertible into or exercisable for capital stock in one or more related transactions primarily for capital raising at a weighted-average common stock equivalent price (the "Weighted-Average Price") below $13.42 per share, the exercise price of a Series Warrant shall reset upon exercise to the midpoint between the initial price and the lowest such Weighted-Average Price, but not below $6.71 per share. The exercise price may be adjusted only once pursuant to this mechanism. F1 · price: On January 13, 2026, pursuant to a registered direct offering by the Issuer, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired warrants to purchase an aggregate of 4,470,936 shares of Common Stock, consisting of (i) Pre-Funded Warrants to purchase 2,235,468 shares of Common Stock, (ii) Series 1 Warrants to purchase 1,117,734 shares of Common Stock and (iii) Series 2 Warrants to purchase 1,117,734 shares of Common Stock (together with the Series 1 Warrants, the "Series Warrants"). The securities were acquired for a purchase price of $6.7099 per Pre-Funded Warrant and accompanying Series Warrants. F2 · ownership.nature: Securities held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, LLC (f/k/a Flagship Pioneering, Inc., "Flagship Pioneering") is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the ultimate control person of Flagship Pioneering. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 17:00 UTC |
Flagship Pioneering, LLCDirector · 10% owner
Flagship Pioneering Fund VII General Partner LLCDirector · 10% owner
Flagship Pioneering Fund VII, L.P.Director · 10% owner
Flagship Pioneering Special Opportunities Fund II General Partner LLCDirector · 10% owner
Flagship Pioneering Special Opportunities Fund II, L.P.Director · 10% owner
Flagship Ventures Fund V General Partner LLCDirector · 10% owner
Flagship Ventures Fund V, L.P.Director · 10% owner
Flagship Ventures Opportunities Fund I General Partner LLCDirector · 10% owner
Flagship Ventures Opportunities Fund I, L.P.Director · 10% owner
Afeyan NoubarDirector · 10% owner
|
GrantPre-Funded Warrants to purchase Common Stock · Derivative | 2,235,468 | $6.71 Strike: $0.00 | $14,999,766.73 |
DisclosureSEC source: 0001193125-26-014218 · ownership.xml · derivative · entry 1 Flagship Pioneering, LLC · CIK 0001400240 · Director · 10% owner Flagship Pioneering Fund VII General Partner LLC · CIK 0001805917 · Director · 10% owner Flagship Pioneering Fund VII, L.P. · CIK 0001805916 · Director · 10% owner Flagship Pioneering Special Opportunities Fund II General Partner LLC · CIK 0001826217 · Director · 10% owner Flagship Pioneering Special Opportunities Fund II, L.P. · CIK 0001761283 · Director · 10% owner Flagship Ventures Fund V General Partner LLC · CIK 0001724575 · Director · 10% owner Flagship Ventures Fund V, L.P. · CIK 0001627639 · Director · 10% owner Flagship Ventures Opportunities Fund I General Partner LLC · CIK 0001725004 · Director · 10% owner Flagship Ventures Opportunities Fund I, L.P. · CIK 0001677345 · Director · 10% owner AFEYAN NOUBAR · CIK 0001222012 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Flagship Pioneering Fund VII, L.P. Disclosed balance after: 2,235,468 Underlying: Common Stock · 2,235,468 shares Expires 2046-01-13 F1 · price: On January 13, 2026, pursuant to a registered direct offering by the Issuer, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired warrants to purchase an aggregate of 4,470,936 shares of Common Stock, consisting of (i) Pre-Funded Warrants to purchase 2,235,468 shares of Common Stock, (ii) Series 1 Warrants to purchase 1,117,734 shares of Common Stock and (iii) Series 2 Warrants to purchase 1,117,734 shares of Common Stock (together with the Series 1 Warrants, the "Series Warrants"). The securities were acquired for a purchase price of $6.7099 per Pre-Funded Warrant and accompanying Series Warrants. F2 · ownership.nature: Securities held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, LLC (f/k/a Flagship Pioneering, Inc., "Flagship Pioneering") is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the ultimate control person of Flagship Pioneering. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:29 UTC |
PARSHALL B LYNNEDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $4.79 Strike: $4.79 | $119,750.00 |
DisclosureSEC source: 0001562180-25-004908 · primarydocument.xml · derivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-16 Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:27 UTC |
GILL SIMBADirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $4.79 Strike: $4.79 | $119,750.00 |
DisclosureSEC source: 0001562180-25-004902 · primarydocument.xml · derivative · entry 1 GILL SIMBA · CIK 0001180763 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-16 Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:25 UTC |
Cole Douglas G.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $4.79 Strike: $4.79 | $119,750.00 |
DisclosureSEC source: 0001562180-25-004893 · primarydocument.xml · derivative · entry 1 Cole Douglas G. · CIK 0001486373 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-16 Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:28 UTC |
Lynch Thomas J. Jr.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $4.79 Strike: $4.79 | $119,750.00 |
DisclosureSEC source: 0001562180-25-004906 · primarydocument.xml · derivative · entry 1 Lynch Thomas J. Jr. · CIK 0001474056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-16 Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:29 UTC |
SMITH IAN FDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $4.79 Strike: $4.79 | $119,750.00 |
DisclosureSEC source: 0001562180-25-004909 · primarydocument.xml · derivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-16 Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:26 UTC |
Biller ScottDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $4.79 Strike: $4.79 | $119,750.00 |
DisclosureSEC source: 0001562180-25-004899 · primarydocument.xml · derivative · entry 1 Biller Scott · CIK 0001581956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-16 Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:28 UTC |
Mendelsohn MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $4.79 Strike: $4.79 | $119,750.00 |
DisclosureSEC source: 0001562180-25-004907 · primarydocument.xml · derivative · entry 1 Mendelsohn Michael · CIK 0001591109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-16 Read SEC document |
| May 01, 2025 Filed May 2, 2025 20:04 UTC |
Gallagher NeilDirector
|
GrantStock Options (Right to buy) · Derivative | 50,000 | $4.16 Strike: $4.16 | $208,000.00 |
DisclosureSEC source: 0001562180-25-003475 · primarydocument.xml · derivative · entry 1 Gallagher Neil · CIK 0001972849 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-04-30 F1 · derivative.exercise_date: The options will vest as to one-third of the underlying shares of common stock on each of the first three anniversaries of the date of grant, subject to the recipient's continuing service on the board of directors. Read SEC document |
| May 01, 2025 Filed May 2, 2025 20:03 UTC |
Duty StuartDirector
|
GrantStock Options (Right to buy) · Derivative | 50,000 | $4.16 Strike: $4.16 | $208,000.00 |
DisclosureSEC source: 0001562180-25-003474 · primarydocument.xml · derivative · entry 1 Duty Stuart · CIK 0001970274 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-04-30 F1 · derivative.exercise_date: The options will vest as to one-third of the underlying shares of common stock on each of the first three anniversaries of the date of grant, subject to the recipient's continuing service on the board of directors. Read SEC document |
| April 25, 2025 Filed Apr 28, 2025 20:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-003257 · primarydocument.xml · nonDerivative · entry 2 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 511,704 F1 · kind: On April 25, 2025, the Adrian H. Gottschalk Living Trust dated September 8, 2009 (the "Gottschalk Living Trust"), of which the Reporting Person is the trustee, distributed 300,000 shares of the Issuer's Common Stock to the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025 (the "Gottschalk 2025 GRAT"), of which the Reporting Person is the trustee and sole current beneficiary. F2 · ownership.nature: Consists of 47,497 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, 300,000 shares held by the Gottschalk 2025 GRAT, and 164,207 shares held by the Gottschalk Living Trust. Read SEC document |
| April 25, 2025 Filed Apr 28, 2025 20:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-003257 · primarydocument.xml · nonDerivative · entry 1 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 511,704 F1 · kind: On April 25, 2025, the Adrian H. Gottschalk Living Trust dated September 8, 2009 (the "Gottschalk Living Trust"), of which the Reporting Person is the trustee, distributed 300,000 shares of the Issuer's Common Stock to the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025 (the "Gottschalk 2025 GRAT"), of which the Reporting Person is the trustee and sole current beneficiary. F2 · ownership.nature: Consists of 47,497 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, 300,000 shares held by the Gottschalk 2025 GRAT, and 164,207 shares held by the Gottschalk Living Trust. Read SEC document |
| April 09, 2025 Filed Apr 10, 2025 20:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 197,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-003092 · primarydocument.xml · nonDerivative · entry 2 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 511,704 F1 · kind: On April 9, 2025, the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary (the "Gottschalk 2023 GRAT"), distributed 197,906 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee (the "Gottschalk Living Trust"). F2 · ownership.nature: Consists of 47,497 shares held by the Gottschalk 2023 GRAT and 464,207 shares held by the Gottschalk Living Trust. Read SEC document |
| April 09, 2025 Filed Apr 10, 2025 20:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 197,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-003092 · primarydocument.xml · nonDerivative · entry 1 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 511,704 F1 · kind: On April 9, 2025, the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary (the "Gottschalk 2023 GRAT"), distributed 197,906 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee (the "Gottschalk Living Trust"). F2 · ownership.nature: Consists of 47,497 shares held by the Gottschalk 2023 GRAT and 464,207 shares held by the Gottschalk Living Trust. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 16:11 UTC |
Rivkin AnnaChief Business Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $4.37 Strike: $4.37 | $218,500.00 |
DisclosureSEC source: 0001562180-25-000502 · primarydocument.xml · derivative · entry 1 Rivkin Anna · CIK 0002035647 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-01-21 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 16:15 UTC |
Humer KristianChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 120,000 | $4.37 Strike: $4.37 | $524,400.00 |
DisclosureSEC source: 0001562180-25-000505 · primarydocument.xml · derivative · entry 1 Humer Kristian · CIK 0001872280 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-01-21 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 16:16 UTC |
Cardama Alfonso QuintasChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 125,000 | $4.37 Strike: $4.37 | $546,250.00 |
DisclosureSEC source: 0001562180-25-000506 · primarydocument.xml · derivative · entry 1 Cardama Alfonso Quintas · CIK 0001760104 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2035-01-21 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:13 UTC |
Costa CarlosChief People Officer
|
GrantStock Option (right to buy) · Derivative | 115,000 | $4.37 Strike: $4.37 | $502,550.00 |
DisclosureSEC source: 0001562180-25-000504 · primarydocument.xml · derivative · entry 1 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2035-01-21 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:10 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 400,000 | $4.37 Strike: $4.37 | $1,748,000.00 |
DisclosureSEC source: 0001562180-25-000501 · primarydocument.xml · derivative · entry 1 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2035-01-21 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:09 UTC |
Bellon Steven F.Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 140,000 | $4.37 Strike: $4.37 | $611,800.00 |
DisclosureSEC source: 0001562180-25-000500 · primarydocument.xml · derivative · entry 1 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2035-01-21 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:06 UTC |
LaCascia MichaelChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 126,000 | $4.37 Strike: $4.37 | $550,620.00 |
DisclosureSEC source: 0001562180-25-000499 · primarydocument.xml · derivative · entry 1 LaCascia Michael · CIK 0001831755 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2035-01-21 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| September 23, 2024 Filed Sep 24, 2024 20:01 UTC |
Costa CarlosChief People Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 857 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001562180-24-006927 · primarydocument.xml · derivative · entry 6 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,789 Underlying: Common Stock · 857 shares Expires 2029-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024. F3 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested. Read SEC document |
| September 23, 2024 Filed Sep 24, 2024 20:01 UTC |
Costa CarlosChief People Officer
|
SaleCommon Stock | 857 | $10.17 | $8,715.69 |
DisclosureSEC source: 0001562180-24-006927 · primarydocument.xml · nonDerivative · entry 4 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024. Read SEC document |
| September 23, 2024 Filed Sep 24, 2024 20:01 UTC |
Costa CarlosChief People Officer
|
Exercise / conversionCommon Stock | 857 | $3.72 | $3,188.04 |
DisclosureSEC source: 0001562180-24-006927 · primarydocument.xml · nonDerivative · entry 3 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024. Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:01 UTC |
Costa CarlosChief People Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 35,756 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001562180-24-006927 · primarydocument.xml · derivative · entry 5 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,646 Underlying: Common Stock · 35,756 shares Expires 2029-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024. F3 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested. Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:01 UTC |
Costa CarlosChief People Officer
|
SaleCommon Stock | 35,756 | $10.04 | $358,990.24 |
DisclosureSEC source: 0001562180-24-006927 · primarydocument.xml · nonDerivative · entry 2 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.22 per share. Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:01 UTC |
Costa CarlosChief People Officer
|
Exercise / conversionCommon Stock | 35,756 | $3.72 | $133,012.32 |
DisclosureSEC source: 0001562180-24-006927 · primarydocument.xml · nonDerivative · entry 1 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 20:00 UTC |
Costa CarlosChief People Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 11,574 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001562180-24-006885 · primarydocument.xml · derivative · entry 3 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,402 Underlying: Common Stock · 11,574 shares Expires 2029-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024. F3 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.